BrachyTalk with Professor Csaba Polgar

Breast Brachytherapy expert Professor Csaba Polgar talks about the opportunities of and his experience with accelerated partial breast irradiation (APBI) brachytherapy, and about new data arising from the GEC-ESTRO phase III APBI trial that was recently published in the Lancet. The study compared multicatheter interstitial  brachytherapy with whole breast irradiation for early breast cancer. The new data that prof Polgar presented at ESTRO 35 show positive cosmesis and favorable late side effects after APBI with multicatheter interstitial brachytherapy, thus further reinforcing APBI brachytherapy as a valid alternative to whole breast irradiation in patients with early breast cancer.